郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Two New Neo-debromoaplysiatoxins-A Pair of Stereoisomers Exhibiting Potent Kv1.5 Ion Channel Inhibition Activities.

期刊：Marine drugs发表年份：2019作者：Ting-Ting Fan; Hui-Hui Zhang; Yang-Hua Tang; Fan-Zhong Zhang; Bing-Nan Han
阅读更多 →

药效评价N-Palmitoylglycine and other N-acylamides activate the lipid receptor G2A/GPR132.

期刊：Pharmacology research & perspectives发表年份：2019作者：James R Foster; Shohta Ueno; Mao Xiang Chen; Jenni Harvey; Simon J Dowell; Andrew J Irving; Andrew J Brown
阅读更多 →

药效评价Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists.

期刊：Neuropharmacology发表年份：2019作者：Darren M Riddy; Anna E Cook; David M Shackleford; Tracie L Pierce; Elisabeth Mocaer; Clotilde Mannoury la Cour; Aurore Sors; William N Charman; Roger J Summers; Patrick M Sexton; Arthur Christopoulos; Christopher J Langmead
阅读更多 →

药效评价Label-free drug screening assay multiplexed with an orthogonal time-resolved fluorescence labeled assay.

期刊：Analytical biochemistry发表年份：2019作者：László Kiss; Attila Cselenyák; András Visegrády
阅读更多 →